BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

585 related articles for article (PubMed ID: 17188338)

  • 1. Persistence of pharmaceuticals and other organic compounds in chlorinated drinking water as a function of time.
    Gibs J; Stackelberg PE; Furlong ET; Meyer M; Zaugg SD; Lippincott RL
    Sci Total Environ; 2007 Feb; 373(1):240-9. PubMed ID: 17188338
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Response to comment on "persistence of pharmaceutical compounds and other organic wastewater contaminants in a conventional drinking-water-treatment plant".
    Stackelberg PE; Furlong ET; Meyer MT; Zaugg SD; Henderson AK; Reissman DB
    Sci Total Environ; 2006 Jan; 354(1):93-7. PubMed ID: 15913713
    [No Abstract]   [Full Text] [Related]  

  • 3. Persistence of pharmaceutical compounds and other organic wastewater contaminants in a conventional drinking-water-treatment plant.
    Stackelberg PE; Furlong ET; Meyer MT; Zaugg SD; Henderson AK; Reissman DB
    Sci Total Environ; 2004 Aug; 329(1-3):99-113. PubMed ID: 15262161
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficiency of conventional drinking-water-treatment processes in removal of pharmaceuticals and other organic compounds.
    Stackelberg PE; Gibs J; Furlong ET; Meyer MT; Zaugg SD; Lippincott RL
    Sci Total Environ; 2007 May; 377(2-3):255-72. PubMed ID: 17363035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Occurrence, genotoxicity, and carcinogenicity of regulated and emerging disinfection by-products in drinking water: a review and roadmap for research.
    Richardson SD; Plewa MJ; Wagner ED; Schoeny R; Demarini DM
    Mutat Res; 2007; 636(1-3):178-242. PubMed ID: 17980649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ozonation and advanced oxidation technologies to remove endocrine disrupting chemicals (EDCs) and pharmaceuticals and personal care products (PPCPs) in water effluents.
    Esplugas S; Bila DM; Krause LG; Dezotti M
    J Hazard Mater; 2007 Nov; 149(3):631-42. PubMed ID: 17826898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A national reconnaissance for pharmaceuticals and other organic wastewater contaminants in the United States--II) untreated drinking water sources.
    Focazio MJ; Kolpin DW; Barnes KK; Furlong ET; Meyer MT; Zaugg SD; Barber LB; Thurman ME
    Sci Total Environ; 2008 Sep; 402(2-3):201-16. PubMed ID: 18433838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Removing emerging contaminants.
    Christen K
    Environ Sci Technol; 2008 Jan; 42(1):6-7. PubMed ID: 18350867
    [No Abstract]   [Full Text] [Related]  

  • 9. Breakpoint chlorination and free-chlorine contact time: implications for drinking water N-nitrosodimethylamine concentrations.
    Charrois JW; Hrudey SE
    Water Res; 2007 Feb; 41(3):674-82. PubMed ID: 16978679
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmaceuticals and other organic chemicals in selected north-central and northwestern Arkansas streams.
    Haggard BE; Galloway JM; Green WR; Meyer MT
    J Environ Qual; 2006; 35(4):1078-87. PubMed ID: 16738393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biostability and disinfectant by-product formation in drinking water blended with UF-treated filter backwash water.
    Walsh ME; Gagnon GA; Alam Z; Andrews RC
    Water Res; 2008 Apr; 42(8-9):2135-45. PubMed ID: 18083207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Occurrence and removal of pharmaceuticals and hormones through drinking water treatment.
    Huerta-Fontela M; Galceran MT; Ventura F
    Water Res; 2011 Jan; 45(3):1432-42. PubMed ID: 21122885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trihalomethane occurrence in chlorinated reclaimed water at full-scale wastewater treatment plants in NE Spain.
    Matamoros V; Mujeriego R; Bayona JM
    Water Res; 2007 Aug; 41(15):3337-44. PubMed ID: 17585988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Variations of biological stability and disinfection byproduct in water distribution systems and their correlations].
    Fang H; Lü XW; Lu JL; Zhu XC
    Huan Jing Ke Xue; 2007 Sep; 28(9):2030-4. PubMed ID: 17990552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmaceuticals, hormones and bisphenol A in untreated source and finished drinking water in Ontario, Canada--occurrence and treatment efficiency.
    Kleywegt S; Pileggi V; Yang P; Hao C; Zhao X; Rocks C; Thach S; Cheung P; Whitehead B
    Sci Total Environ; 2011 Mar; 409(8):1481-8. PubMed ID: 21315426
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Iron and copper release in drinking-water distribution systems.
    Shi B; Taylor JS
    J Environ Health; 2007 Sep; 70(2):29-36, 44, 46. PubMed ID: 17886579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Removal of estrogens through water disinfection processes and formation of by-products.
    Pereira RO; Postigo C; de Alda ML; Daniel LA; Barceló D
    Chemosphere; 2011 Feb; 82(6):789-99. PubMed ID: 21087787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Attenuation of total organic carbon and unregulated trace organic chemicals in U.S. riverbank filtration systems.
    Hoppe-Jones C; Oldham G; Drewes JE
    Water Res; 2010 Aug; 44(15):4643-59. PubMed ID: 20599244
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The detection of pharmaceutical compounds in surface water is a matter of significant interest to the pharmaceutical industry.
    Till AE
    Sci Total Environ; 2005 Nov; 350(1-3):273-5. PubMed ID: 15922409
    [No Abstract]   [Full Text] [Related]  

  • 20. Influence of residual organic macromolecules produced in biological wastewater treatment processes on removal of pharmaceuticals by NF/RO membranes.
    Kimura K; Iwase T; Kita S; Watanabe Y
    Water Res; 2009 Aug; 43(15):3751-8. PubMed ID: 19564034
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.